Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Mier

Showing results (111-120 of 181) with videos related to

Pageof 19
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2017
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with <sup>131</sup>I-MIP-1095Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2016
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617Clemens Kratochwil, Frederik L Giesel, Melsa Stefanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Design and Development of <sup>99m</sup>Tc-Labeled FAPI Tracers for SPECT Imaging and <sup>188</sup>Re TherapyThomas Lindner, Annette Altmann, Susanne Krämer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
A Tumor-Imaging Method Targeting Cancer-Associated FibroblastsAnastasia Loktev, Thomas Lindner, Walter Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Identification and characterization of a peptide with affinity to head and neck cancerEva-Maria Nothelfer, Sabine Zitzmann-Kolbe, Regine Garcia-Boy, et al.
Journal of Hepatology|December 4, 2013
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptorShirin Nkongolo, Yi Ni, Florian A Lempp, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor RetentionAnastasia Loktev, Thomas Lindner, Eva-Maria Burger, et al.
Molecular Imaging and Biology|February 15, 2014
Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CTSarah Wulfert, Clemens Kratochwil, Peter L Choyke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 27, 2013
Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52Walter Mier, Clemens Kratochwil, Jessica C Hassel, et al.
Nuklearmedizin. Nuclear Medicine|May 11, 2019
Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinomaMartin Müller, Annette Altmann, Max Sauter, et al.
Pageof 19

Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2017
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with <sup>131</sup>I-MIP-1095Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2016
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617Clemens Kratochwil, Frederik L Giesel, Melsa Stefanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Design and Development of <sup>99m</sup>Tc-Labeled FAPI Tracers for SPECT Imaging and <sup>188</sup>Re TherapyThomas Lindner, Annette Altmann, Susanne Krämer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
A Tumor-Imaging Method Targeting Cancer-Associated FibroblastsAnastasia Loktev, Thomas Lindner, Walter Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Identification and characterization of a peptide with affinity to head and neck cancerEva-Maria Nothelfer, Sabine Zitzmann-Kolbe, Regine Garcia-Boy, et al.
Journal of Hepatology|December 4, 2013
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptorShirin Nkongolo, Yi Ni, Florian A Lempp, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor RetentionAnastasia Loktev, Thomas Lindner, Eva-Maria Burger, et al.
Molecular Imaging and Biology|February 15, 2014
Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CTSarah Wulfert, Clemens Kratochwil, Peter L Choyke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 27, 2013
Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52Walter Mier, Clemens Kratochwil, Jessica C Hassel, et al.
Nuklearmedizin. Nuclear Medicine|May 11, 2019
Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinomaMartin Müller, Annette Altmann, Max Sauter, et al.
Pageof 19